International Committee
From the three perspectives of international expansion, international harmonization, and contribution to global health, the International Committee deepens cooperation with regulatory authorities, pharmaceutical organizations, and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in various countries and conducts activities to resolve international issues faced by the industry and member companies.
Announcements and Updates
-
International Committee
Information on "World NTD Day 2026" Webinar is now available.
-
International Committee
The "Regular Meeting with the German Association of the Research-based Pharmaceutical Industry (vfa)
-
International Committee
Special Session at the "12th Nikkei-FT Conference on Infectious Diseases
-
International Committee
Report on Side Events Held during the UN General Assembly" is now available.
-
International Committee
Information on "Toward the Formation of a Global Community to Promote Research and Development of Antimicrobial Agents" Webinar is posted.
International Committee Content
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Global Health
Information on Global Health is posted.
-
STOP AMR
The activities of the Pharmaceutical Manufacturers Association of Japan (PMAJ) against drug resistance (AMR) are posted.
-
Statements
Statements of the Pharmaceutical Manufacturers Association of Japan (PMAJ) are posted.
-
DATA (Members only)
Back numbers of overseas news articles and research materials are posted.
-
Announcement from International Committee
Various announcements from the International Committee are posted.
-
Action Fund for Drug Resistance (AMR)
As an IFPMA member organization, the Pharmaceutical Association of Japan contributes to the establishment of this fund and promotes advocacy.